AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | -97.6% | 374 | -87.5% | 0.00% | -100.0% |
| Q2 2020 | $41,000 | +86.4% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $22,000 | +10.0% | 3,000 | -9.1% | 0.00% | 0.0% |
| Q4 2019 | $20,000 | +66.7% | 3,300 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -20.0% | 3,300 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | +114.3% | 3,300 | +312.5% | 0.00% | – |
| Q3 2018 | $7,000 | -30.0% | 800 | -16.7% | 0.00% | -100.0% |
| Q2 2018 | $10,000 | +11.1% | 960 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | -55.0% | 960 | -29.4% | 0.00% | -50.0% |
| Q4 2017 | $20,000 | – | 1,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |